United States · FDA National Drug Code directory
Celecoxib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-056_491c8284-c565-4c6b-8d88-4373b179be4b
- Product NDC
- 71209-056
- Form
- CAPSULE
- Composition / generic term
- Celecoxib
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20151215
- Source listing expiry
- 20261231
Source-listed ingredients
- CELECOXIB — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (71209-056-03) · 71209-056-03
- 100 CAPSULE in 1 BOTTLE (71209-056-05) · 71209-056-05
- 500 CAPSULE in 1 BOTTLE (71209-056-10) · 71209-056-10
- 1000 CAPSULE in 1 BOTTLE (71209-056-11) · 71209-056-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →